Anti-proliferative effect of auriculataoside A on B16 melanoma 4A5 cells by suppression of Cdc42–Rac1–RhoA signaling protein levels

Auriculataoside A, an anthracenone dimer glycoside isolated from Cassia auriculata seed, shows anti-proliferative effects on cell line B16 melanoma 4A5 cells with an IC 50 value of 0.82 μM. However, it shows no such effect on normal human dermal fibroblast (HDF) cells. To evaluate the mode of action...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of natural medicines 2019-06, Vol.73 (3), p.450-455
Hauptverfasser: Wang, Weicheng, Nakashima, Souichi, Nakamura, Seikou, Oda, Yoshimi, Matsuda, Hisashi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 455
container_issue 3
container_start_page 450
container_title Journal of natural medicines
container_volume 73
creator Wang, Weicheng
Nakashima, Souichi
Nakamura, Seikou
Oda, Yoshimi
Matsuda, Hisashi
description Auriculataoside A, an anthracenone dimer glycoside isolated from Cassia auriculata seed, shows anti-proliferative effects on cell line B16 melanoma 4A5 cells with an IC 50 value of 0.82 μM. However, it shows no such effect on normal human dermal fibroblast (HDF) cells. To evaluate the mode of action underlying the anti-proliferative effect of auriculataoside A on cells, we examined changes in whole protein expression after treatment with auriculataoside A and found that the expression Cdc42, RhoA, and Rac1, which are Rho family GTPases, was reduced. Auriculataoside A also arrested the cell cycle at G1 phase. These results suggest that the suppression of the above proteins induced G1 arrest. In addition, auriculataoside A also suppressed the expression of β-catenin and c-Myc proteins. This action of auriculataoside A could be one of the mechanisms underlying its selective anti-proliferative effect on B16 melanoma cells.
doi_str_mv 10.1007/s11418-018-01278-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2179351818</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2179351818</sourcerecordid><originalsourceid>FETCH-LOGICAL-c492t-84a9c9faefc6b4756b65a4fd41569a610cc18d8e7486e939f7c0106159cfa1683</originalsourceid><addsrcrecordid>eNp9kcFuFSEUhidGY2v1BVwYEjduxnKAAWY53tRq0qSJadcTLnO40jDDFWaadOfOB_ANfZIyvVUTFy4Oh4Tv_D_wV9VroO-BUnWaAQTomj4UU2V9Uh2DllBT1vKnZc8FrbkQ_Kh6kfMNpYJxDs-rI04lUy1vjqsf3TT7ep9i8A6Tmf0tEnQO7UyiI2ZJ3i7BzCZmPyDpSJzIB5BkxGCmOBoiuoZYDCGT7R3Jy36fMGdfqDK9Gaxgv77__GIsrO1r7Ej2u8kEP-1I8ZzRTyTgLYb8snrmTMj46rGfVNcfz642n-qLy_PPm-6itqJlc62FaW3rDDort0I1cisbI9wgoJGtkUCtBT1oVEJLbHnrlKVAJTStdQak5ifVu4Nusf-2YJ770ef1AWbCuOSewfovoGFF3_6D3sQlldsXinGqmVKgCsUOlE0x54Su3yc_mnTXA-3XmPpDTD19qBJTT8vQm0fpZTvi8Gfkdy4F4Acgl6Nph-mv939k7wGA_Z6S</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2230827717</pqid></control><display><type>article</type><title>Anti-proliferative effect of auriculataoside A on B16 melanoma 4A5 cells by suppression of Cdc42–Rac1–RhoA signaling protein levels</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Wang, Weicheng ; Nakashima, Souichi ; Nakamura, Seikou ; Oda, Yoshimi ; Matsuda, Hisashi</creator><creatorcontrib>Wang, Weicheng ; Nakashima, Souichi ; Nakamura, Seikou ; Oda, Yoshimi ; Matsuda, Hisashi</creatorcontrib><description>Auriculataoside A, an anthracenone dimer glycoside isolated from Cassia auriculata seed, shows anti-proliferative effects on cell line B16 melanoma 4A5 cells with an IC 50 value of 0.82 μM. However, it shows no such effect on normal human dermal fibroblast (HDF) cells. To evaluate the mode of action underlying the anti-proliferative effect of auriculataoside A on cells, we examined changes in whole protein expression after treatment with auriculataoside A and found that the expression Cdc42, RhoA, and Rac1, which are Rho family GTPases, was reduced. Auriculataoside A also arrested the cell cycle at G1 phase. These results suggest that the suppression of the above proteins induced G1 arrest. In addition, auriculataoside A also suppressed the expression of β-catenin and c-Myc proteins. This action of auriculataoside A could be one of the mechanisms underlying its selective anti-proliferative effect on B16 melanoma cells.</description><identifier>ISSN: 1340-3443</identifier><identifier>EISSN: 1861-0293</identifier><identifier>DOI: 10.1007/s11418-018-01278-0</identifier><identifier>PMID: 30627935</identifier><language>eng</language><publisher>Singapore: Springer Singapore</publisher><subject>Animals ; Biomedical and Life Sciences ; Biomedicine ; cdc42 GTP-Binding Protein - metabolism ; Cell cycle ; Cell Line, Tumor ; Complementary &amp; Alternative Medicine ; Herbal medicine ; Humans ; Medicinal Chemistry ; Melanoma ; Melanoma, Experimental - drug therapy ; Melanoma, Experimental - pathology ; Organic chemicals ; Original Paper ; Pharmacology/Toxicology ; Pharmacy ; Phytochemicals ; Plant Sciences ; Proteins ; rhoA GTP-Binding Protein - metabolism</subject><ispartof>Journal of natural medicines, 2019-06, Vol.73 (3), p.450-455</ispartof><rights>The Japanese Society of Pharmacognosy and Springer Japan KK, part of Springer Nature 2019</rights><rights>The Japanese Society of Pharmacognosy and Springer Japan KK, part of Springer Nature 2019.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c492t-84a9c9faefc6b4756b65a4fd41569a610cc18d8e7486e939f7c0106159cfa1683</citedby><cites>FETCH-LOGICAL-c492t-84a9c9faefc6b4756b65a4fd41569a610cc18d8e7486e939f7c0106159cfa1683</cites><orcidid>0000-0003-4217-065X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11418-018-01278-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11418-018-01278-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30627935$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Weicheng</creatorcontrib><creatorcontrib>Nakashima, Souichi</creatorcontrib><creatorcontrib>Nakamura, Seikou</creatorcontrib><creatorcontrib>Oda, Yoshimi</creatorcontrib><creatorcontrib>Matsuda, Hisashi</creatorcontrib><title>Anti-proliferative effect of auriculataoside A on B16 melanoma 4A5 cells by suppression of Cdc42–Rac1–RhoA signaling protein levels</title><title>Journal of natural medicines</title><addtitle>J Nat Med</addtitle><addtitle>J Nat Med</addtitle><description>Auriculataoside A, an anthracenone dimer glycoside isolated from Cassia auriculata seed, shows anti-proliferative effects on cell line B16 melanoma 4A5 cells with an IC 50 value of 0.82 μM. However, it shows no such effect on normal human dermal fibroblast (HDF) cells. To evaluate the mode of action underlying the anti-proliferative effect of auriculataoside A on cells, we examined changes in whole protein expression after treatment with auriculataoside A and found that the expression Cdc42, RhoA, and Rac1, which are Rho family GTPases, was reduced. Auriculataoside A also arrested the cell cycle at G1 phase. These results suggest that the suppression of the above proteins induced G1 arrest. In addition, auriculataoside A also suppressed the expression of β-catenin and c-Myc proteins. This action of auriculataoside A could be one of the mechanisms underlying its selective anti-proliferative effect on B16 melanoma cells.</description><subject>Animals</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>cdc42 GTP-Binding Protein - metabolism</subject><subject>Cell cycle</subject><subject>Cell Line, Tumor</subject><subject>Complementary &amp; Alternative Medicine</subject><subject>Herbal medicine</subject><subject>Humans</subject><subject>Medicinal Chemistry</subject><subject>Melanoma</subject><subject>Melanoma, Experimental - drug therapy</subject><subject>Melanoma, Experimental - pathology</subject><subject>Organic chemicals</subject><subject>Original Paper</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacy</subject><subject>Phytochemicals</subject><subject>Plant Sciences</subject><subject>Proteins</subject><subject>rhoA GTP-Binding Protein - metabolism</subject><issn>1340-3443</issn><issn>1861-0293</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcFuFSEUhidGY2v1BVwYEjduxnKAAWY53tRq0qSJadcTLnO40jDDFWaadOfOB_ANfZIyvVUTFy4Oh4Tv_D_wV9VroO-BUnWaAQTomj4UU2V9Uh2DllBT1vKnZc8FrbkQ_Kh6kfMNpYJxDs-rI04lUy1vjqsf3TT7ep9i8A6Tmf0tEnQO7UyiI2ZJ3i7BzCZmPyDpSJzIB5BkxGCmOBoiuoZYDCGT7R3Jy36fMGdfqDK9Gaxgv77__GIsrO1r7Ej2u8kEP-1I8ZzRTyTgLYb8snrmTMj46rGfVNcfz642n-qLy_PPm-6itqJlc62FaW3rDDort0I1cisbI9wgoJGtkUCtBT1oVEJLbHnrlKVAJTStdQak5ifVu4Nusf-2YJ770ef1AWbCuOSewfovoGFF3_6D3sQlldsXinGqmVKgCsUOlE0x54Su3yc_mnTXA-3XmPpDTD19qBJTT8vQm0fpZTvi8Gfkdy4F4Acgl6Nph-mv939k7wGA_Z6S</recordid><startdate>20190601</startdate><enddate>20190601</enddate><creator>Wang, Weicheng</creator><creator>Nakashima, Souichi</creator><creator>Nakamura, Seikou</creator><creator>Oda, Yoshimi</creator><creator>Matsuda, Hisashi</creator><general>Springer Singapore</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4217-065X</orcidid></search><sort><creationdate>20190601</creationdate><title>Anti-proliferative effect of auriculataoside A on B16 melanoma 4A5 cells by suppression of Cdc42–Rac1–RhoA signaling protein levels</title><author>Wang, Weicheng ; Nakashima, Souichi ; Nakamura, Seikou ; Oda, Yoshimi ; Matsuda, Hisashi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c492t-84a9c9faefc6b4756b65a4fd41569a610cc18d8e7486e939f7c0106159cfa1683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>cdc42 GTP-Binding Protein - metabolism</topic><topic>Cell cycle</topic><topic>Cell Line, Tumor</topic><topic>Complementary &amp; Alternative Medicine</topic><topic>Herbal medicine</topic><topic>Humans</topic><topic>Medicinal Chemistry</topic><topic>Melanoma</topic><topic>Melanoma, Experimental - drug therapy</topic><topic>Melanoma, Experimental - pathology</topic><topic>Organic chemicals</topic><topic>Original Paper</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacy</topic><topic>Phytochemicals</topic><topic>Plant Sciences</topic><topic>Proteins</topic><topic>rhoA GTP-Binding Protein - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Weicheng</creatorcontrib><creatorcontrib>Nakashima, Souichi</creatorcontrib><creatorcontrib>Nakamura, Seikou</creatorcontrib><creatorcontrib>Oda, Yoshimi</creatorcontrib><creatorcontrib>Matsuda, Hisashi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of natural medicines</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Weicheng</au><au>Nakashima, Souichi</au><au>Nakamura, Seikou</au><au>Oda, Yoshimi</au><au>Matsuda, Hisashi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-proliferative effect of auriculataoside A on B16 melanoma 4A5 cells by suppression of Cdc42–Rac1–RhoA signaling protein levels</atitle><jtitle>Journal of natural medicines</jtitle><stitle>J Nat Med</stitle><addtitle>J Nat Med</addtitle><date>2019-06-01</date><risdate>2019</risdate><volume>73</volume><issue>3</issue><spage>450</spage><epage>455</epage><pages>450-455</pages><issn>1340-3443</issn><eissn>1861-0293</eissn><abstract>Auriculataoside A, an anthracenone dimer glycoside isolated from Cassia auriculata seed, shows anti-proliferative effects on cell line B16 melanoma 4A5 cells with an IC 50 value of 0.82 μM. However, it shows no such effect on normal human dermal fibroblast (HDF) cells. To evaluate the mode of action underlying the anti-proliferative effect of auriculataoside A on cells, we examined changes in whole protein expression after treatment with auriculataoside A and found that the expression Cdc42, RhoA, and Rac1, which are Rho family GTPases, was reduced. Auriculataoside A also arrested the cell cycle at G1 phase. These results suggest that the suppression of the above proteins induced G1 arrest. In addition, auriculataoside A also suppressed the expression of β-catenin and c-Myc proteins. This action of auriculataoside A could be one of the mechanisms underlying its selective anti-proliferative effect on B16 melanoma cells.</abstract><cop>Singapore</cop><pub>Springer Singapore</pub><pmid>30627935</pmid><doi>10.1007/s11418-018-01278-0</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-4217-065X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1340-3443
ispartof Journal of natural medicines, 2019-06, Vol.73 (3), p.450-455
issn 1340-3443
1861-0293
language eng
recordid cdi_proquest_miscellaneous_2179351818
source MEDLINE; SpringerLink Journals
subjects Animals
Biomedical and Life Sciences
Biomedicine
cdc42 GTP-Binding Protein - metabolism
Cell cycle
Cell Line, Tumor
Complementary & Alternative Medicine
Herbal medicine
Humans
Medicinal Chemistry
Melanoma
Melanoma, Experimental - drug therapy
Melanoma, Experimental - pathology
Organic chemicals
Original Paper
Pharmacology/Toxicology
Pharmacy
Phytochemicals
Plant Sciences
Proteins
rhoA GTP-Binding Protein - metabolism
title Anti-proliferative effect of auriculataoside A on B16 melanoma 4A5 cells by suppression of Cdc42–Rac1–RhoA signaling protein levels
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T03%3A04%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-proliferative%20effect%20of%20auriculataoside%20A%20on%20B16%20melanoma%204A5%20cells%20by%20suppression%20of%20Cdc42%E2%80%93Rac1%E2%80%93RhoA%20signaling%20protein%20levels&rft.jtitle=Journal%20of%20natural%20medicines&rft.au=Wang,%20Weicheng&rft.date=2019-06-01&rft.volume=73&rft.issue=3&rft.spage=450&rft.epage=455&rft.pages=450-455&rft.issn=1340-3443&rft.eissn=1861-0293&rft_id=info:doi/10.1007/s11418-018-01278-0&rft_dat=%3Cproquest_cross%3E2179351818%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2230827717&rft_id=info:pmid/30627935&rfr_iscdi=true